Albumin Administration in Acute Ischemic Stroke: Safety Analysis of the ALIAS Part 2 Multicenter Trial.
about
ALIAS (Albumin in Acute Ischemic Stroke) Trials: Analysis of the Combined Data From Parts 1 and 2Bayesian dose selection design for a binary outcome using restricted response adaptive randomization.Critical appraisal of the role of serum albumin in cardiovascular disease.The Migraine Attack as a Homeostatic, Neuroprotective Response to Brain Oxidative Stress: Preliminary Evidence for a Theory.
P2860
Albumin Administration in Acute Ischemic Stroke: Safety Analysis of the ALIAS Part 2 Multicenter Trial.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Albumin Administration in Acut ...... LIAS Part 2 Multicenter Trial.
@ast
Albumin Administration in Acut ...... LIAS Part 2 Multicenter Trial.
@en
type
label
Albumin Administration in Acut ...... LIAS Part 2 Multicenter Trial.
@ast
Albumin Administration in Acut ...... LIAS Part 2 Multicenter Trial.
@en
prefLabel
Albumin Administration in Acut ...... LIAS Part 2 Multicenter Trial.
@ast
Albumin Administration in Acut ...... LIAS Part 2 Multicenter Trial.
@en
P2093
P2860
P1433
P1476
Albumin Administration in Acut ...... LIAS Part 2 Multicenter Trial.
@en
P2093
Claudia S Moy
Creed Pettigrew
David Weisman
Diego Tamariz
Elizabeth B Jones
Karla J Ryckborst
Myron D Ginsberg
Renee H Martin
Yuko Y Palesch
P2860
P304
P356
10.1371/JOURNAL.PONE.0131390
P407
P577
2015-09-01T00:00:00Z